200,000+ products from a single source!

sales@angenechem.com

Home > Amines > 139264-24-7

139264-24-7

139264-24-7 | 2-Oxazolidinone, 4-[[3-[2-(dimethylamino)ethyl]-1H-indol-5-yl]methyl]-, (4R)-

CAS No: 139264-24-7 Catalog No: AG001AL7 MDL No:

Product Description

Catalog Number:
AG001AL7
Chemical Name:
2-Oxazolidinone, 4-[[3-[2-(dimethylamino)ethyl]-1H-indol-5-yl]methyl]-, (4R)-
CAS Number:
139264-24-7
Molecular Formula:
C16H21N3O2
Molecular Weight:
287.3568
IUPAC Name:
(4R)-4-[[3-[2-(dimethylamino)ethyl]-1H-indol-5-yl]methyl]-1,3-oxazolidin-2-one
InChI:
InChI=1S/C16H21N3O2/c1-19(2)6-5-12-9-17-15-4-3-11(8-14(12)15)7-13-10-21-16(20)18-13/h3-4,8-9,13,17H,5-7,10H2,1-2H3,(H,18,20)/t13-/m1/s1
InChI Key:
ULSDMUVEXKOYBU-CYBMUJFWSA-N
SMILES:
CN(CCc1c[nH]c2c1cc(C[C@@H]1COC(=O)N1)cc2)C
UNII:
F3YOE57701

Properties

Complexity:
375  
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
1  
Defined Bond Stereocenter Count:
0
Exact Mass:
287.163g/mol
Formal Charge:
0
Heavy Atom Count:
21  
Hydrogen Bond Acceptor Count:
3  
Hydrogen Bond Donor Count:
2  
Isotope Atom Count:
0
Molecular Weight:
287.363g/mol
Monoisotopic Mass:
287.163g/mol
Rotatable Bond Count:
5  
Topological Polar Surface Area:
57.4A^2
Undefined Atom Stereocenter Count:
0
Undefined Bond Stereocenter Count:
0
XLogP3:
2.2  

Literature

Title Journal
Bioequivalence study of 2 orodispersible formulations of zolmitriptan 5 mg in healthy volunteers. Arzneimittel-Forschung 20121001
A novel relay method for determining low-clearance values. Drug metabolism and disposition: the biological fate of chemicals 20120901
Frovatriptan: a review of its use in the acute treatment of migraine. CNS drugs 20120901
Pharmacokinetic evaluation of zolmitriptan for the treatment of migraines. Expert opinion on drug metabolism & toxicology 20120801
Rheological evaluation of thermoreversible and mucoadhesive nasal gels of Zolmitriptan. European review for medical and pharmacological sciences 20120801
Quantitative determination of zolmitriptan in rat blood and cerebrospinal fluid by reversed phase HPLC-ESI-MS/MS analysis: application to in vivo preclinical pharmacokinetic study. Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20120715
[CME 'Takotsubo cardiomyopathy]. Praxis 20120620
Fast relief from migraine attacks using fast-disintegrating sublingual zolmitriptan tablets. Drug development and industrial pharmacy 20120601
Italian guidelines for primary headaches: 2012 revised version. The journal of headache and pain 20120501
Frovatriptan versus zolmitriptan for the acute treatment of migraine with aura: a subgroup analysis of a double-blind, randomized, multicenter, Italian study. Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology 20120501
Efficacy of frovatriptan versus other triptans in the acute treatment of menstrual migraine: pooled analysis of three double-blind, randomized, crossover, multicenter studies. Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology 20120501
Antidromic vasodilatation and the migraine mechanism. The journal of headache and pain 20120301
Effect of CGRP and sumatriptan on the BOLD response in visual cortex. The journal of headache and pain 20120301
[Pediatric poisoning with triptans: review of cases in the Lille poison center between 2000 and 2010]. Archives de pediatrie : organe officiel de la Societe francaise de pediatrie 20120301
A case of cluster headache accompanied by myoclonus and hemiparesis. Journal of clinical neurology (Seoul, Korea) 20120301
Clinical reasoning: a 62-year-old migraineur with a new kind of headache attacks. Neurology 20120221
[Myocardial infarction after taking zolmitriptan]. Revista portuguesa de cardiologia : orgao oficial da Sociedade Portuguesa de Cardiologia = Portuguese journal of cardiology : an official journal of the Portuguese Society of Cardiology 20120201
Reference programme: diagnosis and treatment of headache disorders and facial pain. Danish Headache Society, 2nd Edition, 2012. The journal of headache and pain 20120201
Identification, preparation and UHPLC determination of process-related impurity in zolmitriptan. Journal of pharmaceutical and biomedical analysis 20120125
Will (or can) people pay for headache care in a poor country? The journal of headache and pain 20120101
Acupuncture as treatment of hot flashes and the possible role of calcitonin gene-related Peptide. Evidence-based complementary and alternative medicine : eCAM 20120101
Central action of peripherally applied botulinum toxin type A on pain and dural protein extravasation in rat model of trigeminal neuropathy. PloS one 20120101
Subcutaneous delivery of sumatriptan in the treatment of migraine and primary headache. Patient preference and adherence 20120101
Zolmitriptan-induced acute myocardial infarction. Cardiology journal 20120101
Preparation and evaluation of zolmitriptan submicron emulsion for rapid and effective nasal absorption in beagle dogs. Drug development and industrial pharmacy 20111201
Efficacy of frovatriptan in the acute treatment of menstrually related migraine: analysis of a double-blind, randomized, cross-over, multicenter, Italian, comparative study versus rizatriptan. The journal of headache and pain 20111201
Suggested randomised, controlled trial with frovatriptan. The journal of headache and pain 20111201
Surface thermodynamics of mucoadhesive dry powder formulation of zolmitriptan. AAPS PharmSciTech 20111201
Evaluation of submicron emulsion as vehicles for rapid-onset intranasal delivery and improvement in brain targeting of zolmitriptan. Drug delivery 20111101
Influence of formulation variables in transdermal drug delivery system containing zolmitriptan. International journal of pharmaceutics 20111031
CONSORT recommendations in abstracts of randomised, controlled trials on migraine and headache. The journal of headache and pain 20111001
Zolmitriptan induced acute coronary syndrome: a unique case. American journal of therapeutics 20110901
Formulation of zolmitriptan sublingual tablets prepared by direct compression with different polymers: in vitro and in vivo evaluation. European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V 20110801
Polysynaptic excitatory postsynaptic potentials that trigger spasms after spinal cord injury in rats are inhibited by 5-HT1B and 5-HT1F receptors. Journal of neurophysiology 20110801
Pharmacotherapy of vestibular and ocular motor disorders, including nystagmus. Journal of neurology 20110701
Guidelines on the diagnosis and the current management of headache and related disorders. Annals of Indian Academy of Neurology 20110701
Optimal balance of efficacy and tolerability of oral triptans and telcagepant: a review and a clinical comment. The journal of headache and pain 20110601
A double-blind, randomized, multicenter, Italian study of frovatriptan versus almotriptan for the acute treatment of migraine. The journal of headache and pain 20110601
When to use frovatriptan in migraine? The journal of headache and pain 20110601
Evolution of paediatric off-label use after new significant medicines become available for adults: a study on triptans in Finnish children 1994-2007. British journal of clinical pharmacology 20110601
Triptan overuse in the Dutch general population: a nationwide pharmaco-epidemiology database analysis in 6.7 million people. Cephalalgia : an international journal of headache 20110601
N-methyl-D-aspartate receptor-mediated modulations of the anti-allodynic effects of 5-HT1B/1D receptor stimulation in a rat model of trigeminal neuropathic pain. European journal of pain (London, England) 20110501
Frovatriptan versus other triptans in the acute treatment of migraine: pooled analysis of three double-blind, randomized, cross-over, multicenter, Italian studies. Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology 20110501
Efficacy of frovatriptan in the acute treatment of menstrually related migraine: analysis of a double-blind, randomized, multicenter, Italian, comparative study versus zolmitriptan. Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology 20110501
A double-blind, randomized, multicenter, Italian study of frovatriptan versus rizatriptan for the acute treatment of migraine. The journal of headache and pain 20110401
Cardiac safety in cluster headache patients using the very high dose of verapamil (≥720 mg/day). The journal of headache and pain 20110401
Neuronal receptor activity-modifying protein 1 promotes energy expenditure in mice. Diabetes 20110401
Triptans other than sumatriptan in child and adolescent migraine: literature review. Expert review of neurotherapeutics 20110301
Why pharmacokinetic differences among oral triptans have little clinical importance: a comment. The journal of headache and pain 20110201
Sustained pain freedom and no adverse events as an endpoint in clinical trials of acute migraine treatments: application to patient-level data from a trial of the CGRP receptor antagonist, telcagepant, and zolmitriptan. Cephalalgia : an international journal of headache 20110201
Acute migraine therapy: new drugs and new approaches. Current treatment options in neurology 20110201
Overview of diagnosis and management of paediatric headache. Part II: therapeutic management. The journal of headache and pain 20110201
Treatment of acute migraine headache. American family physician 20110201
Almotriptan 12.5 mg in menstrually related migraine: a randomized, double-blind, placebo-controlled study. Cephalalgia : an international journal of headache 20110101
Antimigraine efficacy of telcagepant based on patient's historical triptan response. Headache 20110101
Excellent tolerability but relatively low initial clinical efficacy of telcagepant in migraine. Headache 20110101
IL-1β stimulates COX-2 dependent PGE₂ synthesis and CGRP release in rat trigeminal ganglia cells. PloS one 20110101
Brain delivery of valproic acid via intranasal administration of nanostructured lipid carriers: in vivo pharmacodynamic studies using rat electroshock model. International journal of nanomedicine 20110101
Chiral discrimination of drugs by DNA tetranucleotides under electrospray ionisation conditions. European journal of mass spectrometry (Chichester, England) 20110101
Migraine attacks the Basal Ganglia. Molecular pain 20110101
Autoradiographic Mapping of 5-HT(1B/1D) Binding Sites in the Rhesus Monkey Brain Using [carbonyl-C]zolmitriptan. International journal of molecular imaging 20110101
New directions in migraine. BMC medicine 20110101
Calcitonin gene-related peptide (CGRP) and its receptor components in human and rat spinal trigeminal nucleus and spinal cord at C1-level. BMC neuroscience 20110101
A large pharmacy claims-based descriptive analysis of patients with migraine and associated pharmacologic treatment patterns. Neuropsychiatric disease and treatment 20110101
Identification of major degradation products of ketoconazole. Scientia pharmaceutica 20110101
Calcitonin gene-related peptide promotes cellular changes in trigeminal neurons and glia implicated in peripheral and central sensitization. Molecular pain 20110101
The chemical basis of pharmacology. Biochemistry 20101207
The use of triptans for pediatric migraines. Paediatric drugs 20101201
Patients' preference for olanzapine orodispersible tablet compared with conventional oral tablet in a multinational, randomized, crossover study. The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry 20101001
Pharmacotherapy of cluster headache. Expert opinion on pharmacotherapy 20100901
Characterization of the calcitonin gene-related peptide receptor antagonist telcagepant (MK-0974) in human isolated coronary arteries. The Journal of pharmacology and experimental therapeutics 20100901
Triptans for the management of migraine. Drugs 20100820
Acute and preventive pharmacologic treatment of cluster headache. Neurology 20100803
Nitroglycerin provocation in normal subjects is not a useful human migraine model? Cephalalgia : an international journal of headache 20100801
Early responses in randomized clinical trials of triptans in acute migraine treatment. Are they clinically relevant? A comment. Headache 20100701
Zolmitriptan and human aggression: interaction with alcohol. Psychopharmacology 20100701
Frovatriptan versus zolmitriptan for the acute treatment of migraine: a double-blind, randomized, multicenter, Italian study. Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology 20100601
Evolution of migraine-associated symptoms in menstrually related migraine following symptomatic treatment with almotriptan. Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology 20100601
New acute treatments for headache. Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology 20100601
Comparison of the vasoconstrictor effects of the calcitonin gene-related peptide receptor antagonist telcagepant (MK-0974) and zolmitriptan in human isolated coronary arteries. Journal of cardiovascular pharmacology 20100501
Drug dependence associated with triptans and ergot derivatives: a case/non-case study. European journal of clinical pharmacology 20100401
Micellar nanocarriers: potential nose-to-brain delivery of zolmitriptan as novel migraine therapy. Pharmaceutical research 20100401
Anodic voltammetry of zolmitriptan at boron-doped diamond electrode and its analytical applications. Die Pharmazie 20100401
Frovatriptan is Effective and Well Tolerated in Korean Migraineurs: A Double-Blind, Randomized, Placebo-Controlled Trial. Journal of clinical neurology (Seoul, Korea) 20100301
Prinzmetal-variant angina in a patient using zolmitriptan and citalopram. The American journal of emergency medicine 20100201
Non-peptidic antagonists of the CGRP receptor, BIBN4096BS and MK-0974, interact with the calcitonin receptor-like receptor via methionine-42 and RAMP1 via tryptophan-74. Biochemical and biophysical research communications 20100101
Topiramate in the prevention and treatment of migraine: efficacy, safety and patient preference. Neuropsychiatric disease and treatment 20100101
Triptans for acute cluster headache. The Cochrane database of systematic reviews 20100101
Response to Ayurvedic therapy in the treatment of migraine without aura. International journal of Ayurveda research 20100101
A new stability indicating HPLC method for related substances in zolmitriptan. Indian journal of pharmaceutical sciences 20100101
[Update on current care guidelines; childhood headache]. Duodecim; laaketieteellinen aikakauskirja 20100101
Effect of preventive (beta blocker) treatment, behavioural migraine management, or their combination on outcomes of optimised acute treatment in frequent migraine: randomised controlled trial. BMJ (Clinical research ed.) 20100101
Drug interaction and pharmacist. Journal of young pharmacists : JYP 20100101
Synesthesia and migraine: case report. BMC neurology 20100101
Abnormal cortical responses to somatosensory stimulation in medication-overuse headache. BMC neurology 20100101
Cluster headache. BMJ clinical evidence 20100101
Development and Validation of HPTLC Method for the Estimation of Rizatriptan Benzoate in Bulk and Tablets. Indian journal of pharmaceutical sciences 20100101
Extreme thermal sensitivity and pain-induced sensitization in a fibromyalgia patient. Pain research and treatment 20100101
CGRP antagonists: hope for a new era in acute migraine treatment. Acta neurologica Belgica 20091201
Cluster headache in children--experience from a specialist headache clinic. European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society 20091101
Preparation of zolmitriptan-chitosan microparticles by spray drying for nasal delivery. European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences 20091008
Zolmitriptan nasal spray in the acute treatment of cluster headache: a meta-analysis of two studies. Headache 20091001
Uptake/efflux transport of tramadol enantiomers and O-desmethyl-tramadol: focus on P-glycoprotein. Basic & clinical pharmacology & toxicology 20090901
Iatrogenic QT Abnormalities and Fatal Arrhythmias: Mechanisms and Clinical Significance. Current cardiology reviews 20090801
Zolmitriptan compared to propranolol in the treatment of acute neuroleptic-induced akathisia: a comparative double-blind study. European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 20090701
Controlled non-invasive transdermal iontophoretic delivery of zolmitriptan hydrochloride in vitro and in vivo. European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V 20090601
5-Hydroxytryptamine Receptor Subtypes and their Modulators with Therapeutic Potentials. Journal of clinical medicine research 20090601
Vestibular migraine: a critical review of treatment trials. Journal of neurology 20090501
[Induction of rat hepatic cytochrome P-450 3A by zolmitriptan mediated with pregnane X receptor]. Zhejiang da xue xue bao. Yi xue ban = Journal of Zhejiang University. Medical sciences 20090501
Evidence base for the medical treatments used in cluster headache. Current pain and headache reports 20090401
Migraine and telcagepant [corrected]. Lancet (London, England) 20090321
Molecule of the month. Telcagepant. Drug news & perspectives 20090301
A study of the interaction between enantiomers of zolmitriptan and hydroxypropyl-beta-cyclodextrin by capillary electrophoresis. Analytical and bioanalytical chemistry 20090101
Alcohol and cluster headaches. Headache 20090101
Individual triptan selection in migraine attack therapy. Recent patents on CNS drug discovery 20090101
[Cluster headache]. Duodecim; laaketieteellinen aikakauskirja 20090101
Triptans and troponin: a case report. Orphanet journal of rare diseases 20090101
Migraine pathogenesis and state of pharmacological treatment options. BMC medicine 20090101
Rizatriptan for the acute treatment of migraine: Consistency, preference, satisfaction, and quality of life. Patient preference and adherence 20090101
Pediatric migraine. International journal of pediatrics 20090101
Recent advances in the pharmacological management of migraine. F1000 medicine reports 20090101
Efficacy and tolerability of MK-0974 (telcagepant), a new oral antagonist of calcitonin gene-related peptide receptor, compared with zolmitriptan for acute migraine: a randomised, placebo-controlled, parallel-treatment trial. Lancet (London, England) 20081220
CGRP-receptor antagonism in migraine treatment. Lancet (London, England) 20081220
Male-specific induction of CYP3A2 in rats by zolmitriptan. The Journal of pharmacy and pharmacology 20081201
Treatment satisfaction and efficacy of the rapid release formulation of sumatriptan 100 mg tablets utilising an early intervention paradigm in patients previously unsatisfied with sumatriptan. International journal of clinical practice 20081201
Prophylaxis of migraine: general principles and patient acceptance. Neuropsychiatric disease and treatment 20081201
Difference in triptan effect in patients with migraine and early allodynia. Cephalalgia : an international journal of headache 20081001
Optimizing prophylactic treatment of migraine: Subtypes and patient matching. Therapeutics and clinical risk management 20081001
In vitro inhibition of CYP1A2 by model inhibitors, anti-inflammatory analgesics and female sex steroids: predictability of in vivo interactions. Basic & clinical pharmacology & toxicology 20080801
Tactile-induced ultrasonic vocalization in the rat: a novel assay to assess anti-migraine therapies in vivo. Cephalalgia : an international journal of headache 20080701
Indolealkylamines: biotransformations and potential drug-drug interactions. The AAPS journal 20080601
Management of migraine in adolescents. Neuropsychiatric disease and treatment 20080601
Treatment of children with migraine in the emergency department: a qualitative systematic review. Pediatric emergency care 20080501
Effectiveness of zolmitriptan nasal spray for the acute treatment of cluster headache: study 1. Current neurology and neuroscience reports 20080301
Effectiveness of zolmitriptan nasal spray for the acute treatment of cluster headache: study 2. Current neurology and neuroscience reports 20080301
Cluster headache. BMJ clinical evidence 20080215
Meta-analysis of the efficacy and safety of zolmitriptan in the acute treatment of migraine. Headache 20080201
Fabrication of molecularly imprinted hybrid monoliths via a room temperature ionic liquid-mediated nonhydrolytic sol-gel route for chiral separation of zolmitriptan by capillary electrochromatography. Electrophoresis 20080201
Treatment of migraine attacks based on the interaction with the trigemino-cerebrovascular system. The journal of headache and pain 20080201
Triptans in pregnancy. Therapeutic drug monitoring 20080201
Review of frovatriptan in the treatment of migraine. Neuropsychiatric disease and treatment 20080201
Acute treatment of paediatric migraine: a meta-analysis of efficacy. Journal of paediatrics and child health 20080101
Almotriptan, an antimigraine agent, and its malate salt. Acta crystallographica. Section C, Crystal structure communications 20080101
Gender differences in sex life issues - a population-based study of migraine sufferers. BMC family practice 20080101
A computerized infusion pump for control of tissue tracer concentration during positron emission tomography in vivo pharmacokinetic/pharmacodynamic measurements. BMC medical physics 20080101
Cluster headache. Orphanet journal of rare diseases 20080101
Oral zolmitriptan in the short-term prevention of menstrual migraine: a randomized, placebo-controlled study. CNS drugs 20080101
Sumatriptan inhibits synaptic transmission in the rat midbrain periaqueductal grey. Molecular pain 20080101
The treatment of migraine headaches in children and adolescents. The journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG 20080101
Clinical pharmacology of the serotonin receptor agonist, zolmitriptan. Expert opinion on drug metabolism & toxicology 20071201
Almotriptan in the treatment of migraine. Neuropsychiatric disease and treatment 20071201
Renal ischaemic injuries during the use of zolmitriptan for treatment of migraines in a transplanted patient under tacrolimus therapy. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 20071101
[Muscle cramps and myalgia related to zolmitriptan]. Revista de neurologia 20071101
Pharmacokinetic and pharmacodynamic variability as possible causes for different drug responses in migraine. A comment. Cephalalgia : an international journal of headache 20071001
Use of almotriptan in triptan-experienced and triptan-naïve patients. Current medical research and opinion 20071001
[Trigeminal autonomic cephalgias: diagnostic and therapeutic implications]. MMW Fortschritte der Medizin 20070906
Patterns of triptans use: a study based on the records of a community pharmaceutical department. Cephalalgia : an international journal of headache 20070901
Patient preference for triptan formulations: a prospective study with zolmitriptan. Headache 20070901
Marketed oral triptans in the acute treatment of migraine: a systematic review on efficacy and tolerability. Headache 20070901
Meta-analysis examining the efficacy and safety of almotriptan in the acute treatment of migraine. Headache 20070901
Zolmitriptan nasal spray in the acute treatment of cluster headache: a double-blind study. Neurology 20070828
Acute renal failure in a 17-year-old female with ALL receiving escalating intravenous methotrexate without leukovorin. Pediatric blood & cancer 20070801
Economic analysis of triptan therapy for acute migraine: a Medicaid perspective. Pharmacotherapy 20070801
Efficacy of zolmitriptan nasal spray in adolescent migraine. Pediatrics 20070801
The impact of migraine: a case study. The Journal of neuroscience nursing : journal of the American Association of Neuroscience Nurses 20070801
Times to pain relief and pain freedom with rizatriptan 10 mg and other oral triptans. International journal of clinical practice 20070701
The 1:1 inclusion compounds zolmitriptan-benzene and zolmitriptan-phenol. Acta crystallographica. Section C, Crystal structure communications 20070701
Characterization of the human basilar artery contractile response to 5-HT and triptans. Fundamental & clinical pharmacology 20070601
Acute migraine: Current treatment and emerging therapies. Therapeutics and clinical risk management 20070601
Transport characteristics of zolmitriptan in a human intestinal epithelial cell line Caco-2. The Journal of pharmacy and pharmacology 20070501
Treatment of childhood migraine attacks with oral zolmitriptan and ibuprofen. Neurology 20070424
[Intranasal zolmitriptan acts quickly]. Medizinische Monatsschrift fur Pharmazeuten 20070301
Almotriptan and zolmitriptan in the acute treatment of migraine. Acta neurologica Scandinavica 20070101
Effectiveness and satisfaction with zolmitriptan 5 mg nasal spray for treatment of migraine in real-life practice: results of a postmarketing surveillance study. Clinical drug investigation 20070101
Use of the sustained pain-free plus no adverse events endpoint in clinical trials of triptans in acute migraine. CNS drugs 20070101
Hemifacial spasm and cluster headache. Cephalalgia : an international journal of headache 20070101
Extractive spectrophotometric methods for determination of zolmitriptan in tablets. Journal of AOAC International 20070101
Improved migraine management in primary care: results of a patient treatment experience study using zolmitriptan orally disintegrating tablet. International journal of clinical practice 20061201
Pharmacokinetics and interactions of headache medications, part I: introduction, pharmacokinetics, metabolism and acute treatments. Expert opinion on drug metabolism & toxicology 20061201
Effectiveness of intranasal zolmitriptan in acute cluster headache: a randomized, placebo-controlled, double-blind crossover study. Archives of neurology 20061101
Nasal delivery of antimigraine drugs: clinical rationale and evidence base. Headache 20061101
Tailoring management strategies for the patient with menstrual migraine: focus on prevention and treatment. Headache 20061001
Zolmitriptan uptake by human intestinal epithelial Caco-2 cells. Die Pharmazie 20061001
Frovatriptan: a review of pharmacology, pharmacokinetics and clinical potential in the treatment of menstrual migraine. Therapeutics and clinical risk management 20060901
Rizatriptan in the treatment of migraine. Neuropsychiatric disease and treatment 20060901
Topiramate in the prevention of migraine: a review of its efficacy, tolerability, and acceptability. Neuropsychiatric disease and treatment 20060901
Treatment of childhood migraine attacks with oral zolmitriptan and ibuprofen. Neurology 20060808
The impact of different antimigraine compounds on platelet and erythrocyte aggregation. Cephalalgia : an international journal of headache 20060801
Daily morning hemifacial spasm in a patient with cluster headache. Cephalalgia : an international journal of headache 20060601
Efficacy and tolerability of almotriptan versus zolmitriptan for the acute treatment of menstrual migraine. Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology 20060501
[Symptomatic treatment of migraine with zolmitriptan: experience with 82 patients]. Neurologia (Barcelona, Spain) 20060501
The pharmacological treatment options for pediatric migraine: an evidence-based appraisal. NeuroRx : the journal of the American Society for Experimental NeuroTherapeutics 20060401
[Experience with intranasal zolmitriptan in cluster headache]. Neurologia (Barcelona, Spain) 20060401
Determination of zolmitriptan in human plasma by liquid chromatography-tandem mass spectrometry method: application to a pharmacokinetic study. Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20060217
Blood-brain barrier penetration of zolmitriptan--modelling of positron emission tomography data. Journal of pharmacokinetics and pharmacodynamics 20060201
Zolmitriptan oral tablet in migraine treatment: high placebo responses in adolescents. Headache 20060101
Zolmitriptan intranasal: a review of the pharmacokinetics and clinical efficacy. Headache 20060101
[Medical treatment of migraine attacks in the child]. Revue de l'infirmiere 20060101
Antimigraine drug, zolmitriptan, inhibits high-voltage activated calcium currents in a population of acutely dissociated rat trigeminal sensory neurons. Molecular pain 20060101
Renal infarction during the use of rizatriptan and zolmitriptan: two case reports. Clinical toxicology (Philadelphia, Pa.) 20060101
Eletriptan: a review of its use in the acute treatment of migraine. Drugs 20060101
[Clinical use of triptans in the management of migraine]. CNS drugs 20060101
Spotlight on eletriptan in migraine. CNS drugs 20060101
Efficacy and tolerability of zolmitriptan oral tablet in the acute treatment of menstrual migraine. CNS drugs 20060101
A comparative study on the cost of new antibiotics and drugs of other therapeutic categories. PloS one 20060101
Distribution of intranasal C-zolmitriptan assessed by positron emission tomography. Cephalalgia : an international journal of headache 20051201
The study of enantioseparation of zolmitriptan on vancomycin-bonded chiral stationary phase. Journal of separation science 20051201
Over-the-counter triptans--making the switch. The Lancet. Neurology 20051001
[The role of triptans and analgesics for primary headache treatment]. Nihon rinsho. Japanese journal of clinical medicine 20051001
A stability indicating LC method for zolmitriptan. Journal of pharmaceutical and biomedical analysis 20050915
A validated chiral LC method for the enantiomeric separation of Zolmitriptan key intermediate, ZTR-5. Journal of pharmaceutical and biomedical analysis 20050915
The use of multiattribute decision models in evaluating triptan treatment options in migraine. Journal of neurology 20050901
[Extrahepatic cholestasia during therapy with Zolmitriptan (AscoTop)]. Zeitschrift fur Gastroenterologie 20050901
Sumatriptan and zolmitriptan. Nursing times 20050901
Updated overview of the putative role of the serotoninergic system in obsessive-compulsive disorder. Neuropsychiatric disease and treatment 20050901
Multiple attack study on the available triptans in Italy versus placebo. European journal of neurology 20050701
Intranasal zolmitriptan. Expert opinion on pharmacotherapy 20050601
The treatment of pediatric migraine. Pediatric annals 20050601
Intranasal mucoadhesive microemulsions of zolmitriptan: preliminary studies on brain-targeting. Journal of drug targeting 20050601
Rapid and sensitive liquid chromatography-tandem mass spectrometry method for the quantitation of levodropropizine in human plasma. Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20050505
Triptans induce vasoconstriction of human arteries and veins from the thoracic wall. Journal of cardiovascular pharmacology 20050501
Anti-migraine action of triptans is preceded by transient aggravation of headache caused by activation of meningeal nociceptors. Pain 20050501
Myocardial infarction after taking zolmitriptan. The Yale journal of biology and medicine 20050501
Determination of zolmitriptan enantiomers in rat liver microsomes by chiral high performance liquid chromatography with fl uorescence detection. Biomedical chromatography : BMC 20050401
[Economic evaluation of acute migraine attack treatment with triptans in Spain]. Neurologia (Barcelona, Spain) 20050401
Pediatric migraine: recognition and treatment. The Journal of the American Osteopathic Association 20050401
Eletriptan review. Expert opinion on pharmacotherapy 20050401
A validated chiral LC method for the determination of zolmitriptan and its potential impurities. Journal of pharmaceutical and biomedical analysis 20050309
Pain-free rates with zolmitriptan 2.5 mg ODT in the acute treatment of migraine: results of a large double-blind placebo- controlled trial. Current medical research and opinion 20050301
Triptan nonresponder studies: implications for clinical practice. Headache 20050201
The 5-HT1D receptor agonist zolmitriptan for neuroleptic-induced akathisia: an open label preliminary study. International clinical psychopharmacology 20050101
Correlation between lipophilicity and triptan outcomes. Headache 20050101
Zolmitriptan 5 mg nasal spray: efficacy and onset of action in the acute treatment of migraine--results from phase 1 of the REALIZE Study. Headache 20050101
Zolmitriptan nasal spray exhibits good long-term safety and tolerability in migraine: results of the INDEX trial. Headache 20050101
Speed of onset, efficacy and tolerability of zolmitriptan nasal spray in the acute treatment of migraine: a randomised, double-blind, placebo-controlled study. CNS drugs 20050101
Distribution of zolmitriptan into the CNS in healthy volunteers: a positron emission tomography study. Drugs in R&D 20050101
[Management costs of chest and CNS-related adverse events associated with the treatment of acute migraine attacks with oral triptans]. Neurologia (Barcelona, Spain) 20050101
Part II: clinical efficacy and tolerability of zolmitriptan orally disintegrating tablet in the acute treatment of migraine. Current medical research and opinion 20050101
Part III: the convenience of, and patient preference for, zolmitriptan orally disintegrating tablet. Current medical research and opinion 20050101
Part IV: effects of zolmitriptan orally disintegrating tablet on migraine symptoms and ability to perform normal activities: a post-marketing surveillance study in Germany. Current medical research and opinion 20050101
An economic evaluation of rizatriptan in the treatment of migraine. PharmacoEconomics 20050101
[Probabilistic cost-effectiveness analysis of oral eletriptan in the treatment of acute migraine in Portugal]. Acta medica portuguesa 20050101
Myalgia and cramps associated with zolmitriptan. Clinical neuropharmacology 20050101
The use of triptans in the management of menstrual migraine. CNS drugs 20050101
Rizatriptan: a pharmacoeconomic review of its use in the acute treatment of migraine. PharmacoEconomics 20050101
Treatment satisfaction with zolmitriptan nasal spray for migraine in a real life setting: results from phase two of the REALIZE study. The journal of headache and pain 20050101
Bioequivalence and rapid absorption of zolmitriptan nasal spray compared with oral tablets in healthy Japanese subjects. Clinical drug investigation 20050101
Practice parameter: pharmacological treatment of migraine headache in children and adolescents: report of the American Academy of Neurology Quality Standards Subcommittee and the Practice Committee of the Child Neurology Society. Neurology 20041228
Quantification of zolmitriptan in plasma by high-performance liquid chromatography-electrospray ionization mass spectrometry. Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20041225
[Determination of levodropropizine and its pharmacokinetics in human plasma using LC/MS/MS]. Yao xue xue bao = Acta pharmaceutica Sinica 20041201
Role of alcohol consumption in escalation to violence. Annals of the New York Academy of Sciences 20041201
Benefits of treating highly disabled migraine patients with zolmitriptan while pain is mild. Cephalalgia : an international journal of headache 20041101
Migraine treatment strategies: the global Migraine And Zolmitriptan Evaluation (MAZE) survey--phase IV. Current medical research and opinion 20041101
Acute myocardial infarction following the use of antimigraine therapy. The Journal of invasive cardiology 20041001
Cluster headache: symptomatic treatment. Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology 20041001
[Triptans in migraine: a comparative review of pharmacology, pharmacokinetics]. No to shinkei = Brain and nerve 20040901
[Triptans in migraine: from clinical view]. No to shinkei = Brain and nerve 20040901
[Meta-analysis of triptan treatment in migraine]. No to shinkei = Brain and nerve 20040901
[Side effects of triptans]. No to shinkei = Brain and nerve 20040901
Differences of anti-nociceptive mechanisms of migraine drugs on the trigeminal pain processing during and outside acute migraine attacks. Cephalalgia : an international journal of headache 20040801
The therapeutic profile of zolmitriptan in clinical practice. International journal of clinical practice 20040801
Involvement of 5-HT1B receptors in triptan-induced contractile responses in guinea-pig isolated iliac artery. Naunyn-Schmiedeberg's archives of pharmacology 20040701
Impact of migraine on patients and their families: the Migraine And Zolmitriptan Evaluation (MAZE) survey--Phase III. Current medical research and opinion 20040701
Triptans and CNS side-effects: pharmacokinetic and metabolic mechanisms. Cephalalgia : an international journal of headache 20040601
Transformed migraine and medication overuse in a tertiary headache centre--clinical characteristics and treatment outcomes. Cephalalgia : an international journal of headache 20040601
Migraine headache. Clinical evidence 20040601
High-performance liquid chromatographic analysis of zolmitriptan in human plasma using fluorescence detection. Journal of pharmaceutical and biomedical analysis 20040528
Double-blind clinical trials of oral triptans vs other classes of acute migraine medication - a review. Cephalalgia : an international journal of headache 20040501
Effects of chronic sumatriptan and zolmitriptan treatment on 5-HT receptor expression and function in rats. Cephalalgia : an international journal of headache 20040501
[Unstable angina in relationship to intake of zolmitriptan]. Neurologia (Barcelona, Spain) 20040501
Patients with migraine prefer zolmitriptan orally disintegrating tablet to sumatriptan conventional oral tablet. International journal of clinical practice 20040301
Efficacy and tolerability of oral zolmitriptan in menstrually associated migraine: a randomized, prospective, parallel-group, double-blind, placebo-controlled study. Headache 20040201
Naratriptan for the treatment of acute migraine: meta-analysis of randomised controlled trials. Pharmacoepidemiology and drug safety 20040201
Managing migraines. New treatments focus on relieving pain fast--or heading off these headaches before they begin. Health news (Waltham, Mass.) 20040201
Zolmitriptan (Zomig) nasal spray for migraine. The Medical letter on drugs and therapeutics 20040119
Effects of acute or chronic administration of anti-migraine drugs sumatriptan and zolmitriptan on serotonin synthesis in the rat brain. Cephalalgia : an international journal of headache 20040101
Defeating migraine pain with triptans: a race against the development of cutaneous allodynia. Annals of neurology 20040101
[HPLC determination of zolmitriptan and its related substances]. Zhejiang da xue xue bao. Yi xue ban = Journal of Zhejiang University. Medical sciences 20040101
Fixed drug eruption of the penis due to zolmitriptan. Dermatology (Basel, Switzerland) 20040101
Patterns of use of triptans and reasons for switching them in a tertiary care migraine population. Headache 20040101
Determining triptan preference for the individual patient. Headache 20040101
Rizatriptan versus rizatriptan plus rofecoxib versus rizatriptan plus tolfenamic acid in the acute treatment of migraine. BMC neurology 20040101
Intranasal medications for the treatment of migraine and cluster headache. CNS drugs 20040101
[Treatment of migraine]. Medicinski arhiv 20040101
Acute treatment of migraine with zolmitriptan 5 mg orally disintegrating tablet. CNS drugs 20040101
Zolmitriptan (Zomig). Expert review of neurotherapeutics 20040101
In vitro metabolism of zolmitriptan in rat cytochromes induced with beta-naphthoflavone and the interaction between six drugs and zolmitriptan. Chemico-biological interactions 20031215
[Zolmitriptan-induced hepatotoxicity]. Gastroenterologia y hepatologia 20031201
Comparative efficacy of eletriptan and zolmitriptan in the acute treatment of migraine. Cephalalgia : an international journal of headache 20031201
Migraine headache. Clinical evidence 20031201
Zolmitriptan nasal spray: advances in migraine treatment. Neurology 20031028
Clinical applications of new therapeutic deliveries in migraine. Neurology 20031028
Abnormal habituation of 'nociceptive' blink reflex in migraine--evidence for increased excitability of trigeminal nociception. Cephalalgia : an international journal of headache 20031001
Patients with migraine prefer zolmitriptan orally disintegrating tablet to sumatriptan conventional oral tablet. International journal of clinical practice 20030901
Eletriptan metabolism by human hepatic CYP450 enzymes and transport by human P-glycoprotein. Drug metabolism and disposition: the biological fate of chemicals 20030701
The evolving management of migraine. Current opinion in neurology 20030601
[Improved pharmacokinetics. Fast tryptan with sustained response]. MMW Fortschritte der Medizin 20030526
[Highly selective beginning. Associated symptoms and side effects in retrospect]. MMW Fortschritte der Medizin 20030526
Topical agents in the treatment of cluster headache. Current pain and headache reports 20030401
Zolmitriptan for treatment of migrainous vertigo: a pilot randomized placebo-controlled trial. Neurology 20030311
Safety profile of the triptans. Expert opinion on drug safety 20030301
Migraine: pathophysiology, pharmacology, treatment and future trends. Current vascular pharmacology 20030301
[Zolmitriptan as fast-melt tablet in the acute treatment of patients with migraine attacks: the ZORO study]. Praxis 20030226
Reassessing the contraindication of zolmitriptan and serotonin reuptake inhibitors: an evidence-based pharmacotherapeutic case report. Journal of clinical pharmacy and therapeutics 20030201
[Triptane. Zolmitriptan--fast and effective in migraine]. Schmerz (Berlin, Germany) 20030101
Speed of onset and efficacy of zolmitriptan nasal spray in the acute treatment of migraine: a randomised, double-blind, placebo-controlled, dose-ranging study versus zolmitriptan tablet. CNS drugs 20030101
Pharmacological approaches to migraine. Journal of neural transmission. Supplementum 20030101
Migraine prevalence and treatment patterns: the global Migraine and Zolmitriptan Evaluation survey. Headache 20030101
Coprescription of triptans with potentially interacting medications: a cohort study involving 240,268 patients. Headache 20030101
Transcranial Doppler in migraine attacks before and after treatment with oral zolmitriptan or sumatriptan. Headache 20030101
Management of trigeminal autonomic cephalgias and hemicrania continua. Drugs 20030101
Tolerability and consistency of effect of zolmitriptan nasal spray in a long-term migraine treatment trial. CNS drugs 20030101
Migraine: diagnosis and management. Internal medicine journal 20030101
Newer formulations of the triptans: advances in migraine management. Drugs 20030101
Meta-analysis of oral triptan therapy for migraine: number needed to treat and relative cost to achieve relief within 2 hours. Journal of managed care pharmacy : JMCP 20030101
Impact of antimigraine compounds on cognitive processing: a placebo-controlled crossover study. Headache 20030101
The antimigraine 5-HT 1B/1D receptor agonists, sumatriptan, zolmitriptan and dihydroergotamine, attenuate pain-related behaviour in a rat model of trigeminal neuropathic pain. British journal of pharmacology 20021201
Ergot and triptan overuse in Austria--an evaluation of clinical data and cost. Cephalalgia : an international journal of headache 20021201
Preliminary studies of the pharmacokinetics and tolerability of zolmitriptan nasal spray in healthy volunteers. Journal of clinical pharmacology 20021101
Pharmacokinetics, dose proportionality, and tolerability of single and repeat doses of a nasal spray formulation of zolmitriptan in healthy volunteers. Journal of clinical pharmacology 20021101
Social and neural determinants of aggressive behavior: pharmacotherapeutic targets at serotonin, dopamine and gamma-aminobutyric acid systems. Psychopharmacology 20021001
Triptans (serotonin, 5-HT1B/1D agonists) in migraine: detailed results and methods of a meta-analysis of 53 trials. Cephalalgia : an international journal of headache 20021001
Cerebral vasoconstriction and stroke after use of serotonergic drugs. Neurology 20020827
Triptans reduce the inflammatory response in bacterial meningitis. Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism 20020801
Selegiline: a second look. Six years later: too risky in Parkinson's disease. Prescrire international 20020801
Review of zolmitriptan and its clinical applications in migraine. Expert opinion on pharmacotherapy 20020701
Mechanisms of action of the 5-HT1B/1D receptor agonists. Archives of neurology 20020701
The pharmacokinetics of the antimigraine compound zolmitriptan in Japanese and Caucasian subjects. European journal of clinical pharmacology 20020701
Efficacy of oral ketoprofen in acute migraine: a double-blind randomized clinical trial. Neurology 20020611
Zolmitriptan is effective and well tolerated in Japanese patients with migraine: a dose-response study. Cephalalgia : an international journal of headache 20020601
Gateways to Clinical Trials. June 2002. Methods and findings in experimental and clinical pharmacology 20020601
Acute migraine headache: possible sensitization of neurons in the spinal trigeminal nucleus? Neurology 20020423
Zolmitriptan orally disintegrating tablet is effective in the acute treatment of migraine. Cephalalgia : an international journal of headache 20020301
[Splenic infarction associated with Zolmitriptan use]. Gastroenterologie clinique et biologique 20020301
Molecular cloning and expression of the porcine trigeminal ganglion cDNA encoding a 5-ht(1F) receptor. European journal of pharmacology 20020201
Re: Zakrzewska JM. Cluster headache: review of the literature. Br J Oral Maxillofac Surg 2001; 39: 103-113. The British journal of oral & maxillofacial surgery 20020201
Comparison of triptan tablet consumption per attack: a prospective study of migraineurs in Spain. Headache 20020201
Simultaneous measurement of zolmitriptan and its major metabolites N-desmethylzolmitriptan and zolmitriptan N-oxide in human plasma by high-performance liquid chromatography with coulometric detection. Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20020125
[Treatment of migraine in patients with hypertension and ischemic heart disease]. Ideggyogyaszati szemle 20020120
Zolmitriptan versus a combination of acetylsalicylic acid and metoclopramide in the acute oral treatment of migraine: a double-blind, randomised, three-attack study. European neurology 20020101
[Migraine: a disease, not a symptom]. La Revue du praticien 20020101
Cost-effectiveness analysis of stratified versus stepped care strategies for acute treatment of migraine: The Disability in Strategies for Care (DISC) Study. PharmacoEconomics 20020101
Rizatriptan: an update of its use in the management of migraine. Drugs 20020101
Patient perceptions and treatment preferences in migraine management. CNS drugs 20020101
Spotlight on rizatriptan in migraine. CNS drugs 20020101
Restoring migraine sufferers' ability to function normally: a comparison of rizatriptan and other triptans in randomized trials. European neurology 20020101
An introduction to migraine: from ancient treatment to functional pharmacology and antimigraine therapy. Proceedings of the Western Pharmacology Society 20020101
[The problems of migraine headache treatment]. Medicina (Kaunas, Lithuania) 20020101
A comparison of familial and sporadic migraine in a headache clinic population. Functional neurology 20020101
Oral triptans (serotonin 5-HT(1B/1D) agonists) in acute migraine treatment: a meta-analysis of 53 trials. Lancet (London, England) 20011117
Clinical features of withdrawal headache following overuse of triptans and other headache drugs. Neurology 20011113
[Cost effectiveness of treatment with triptanes in Spain]. Revista de neurologia 20011101
Comparison of rizatriptan and other triptans on stringent measures of efficacy. Neurology 20011023
Patient satisfaction with rizatriptan versus other triptans: direct head-to-head comparisons. International journal of clinical practice 20011001
Assessing patient preference in migraine treatment. Cephalalgia : an international journal of headache 20011001
Advances in pharmacological treatment of migraine. Expert opinion on investigational drugs 20011001
Have the triptans fulfilled their promise? Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia 20010901
Triptans are all different. Archives of neurology 20010901
What matters is not the differences between triptans, but the differences between patients. Archives of neurology 20010901
Effect of rizatriptan and other triptans on the nausea symptom of migraine: a post hoc analysis. Headache 20010901
Dexamethasone decreases migraine recurrence observed after treatment with a triptan combined with a nonsteroidal anti-inflammatory drug. Arquivos de neuro-psiquiatria 20010901
Zolmitriptan--a 5-HT1B/D agonist, alcohol, and aggression in mice. Psychopharmacology 20010901
Serotonergic effects and extracellular brain levels of eletriptan, zolmitriptan and sumatriptan in rat brain. European journal of pharmacology 20010817
Establishing a standard of speed for assessing the efficacy of the serotonin(1B/1D) agonists (triptans). Archives of neurology 20010701
Molecular cloning, pharmacological properties and tissue distribution of the porcine 5-HT(1B) receptor. British journal of pharmacology 20010701
Safety and rational use of the triptans. The Medical clinics of North America 20010701
An open preference study with sumatriptan 50 mg and zolmitriptan 2.5 mg in 100 migraine patients. Cephalalgia : an international journal of headache 20010701
Recent development in paediatric headache. Current opinion in neurology 20010601
Current options for the prevention and treatment of migraine. Clinical therapeutics 20010601
Migraine treatment outcomes with rizatriptan in triptan-naive patients: a naturalistic study. Clinical therapeutics 20010601
Zolmitriptan versus sumatriptan for the acute oral treatment of migraine: a randomized, double-blind, international study. European journal of neurology 20010501
Decreased sensitivity of 5-HT(1D) receptors in melancholic depression. The British journal of psychiatry : the journal of mental science 20010501
Effect of MAO-A inhibition on the pharmacokinetics of almotriptan, an antimigraine agent in humans. British journal of clinical pharmacology 20010501
[Current topics: expectation for new triptans]. Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine 20010410
Sumatriptan, 5-HT(1D) receptors and obsessive-compulsive disorder. European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 20010401
4991W93 inhibits release of calcitonin gene-related peptide in the cat but only at doses with 5HT(1B/1D) receptor agonist activity? Neuropharmacology 20010301
Zolmitriptan versus sumatriptan comparison trial. Headache 20010301
Donitriptan (Pierre Fabre). Current opinion in investigational drugs (London, England : 2000) 20010301
Acute treatment of migraine and the role of triptans. Current neurology and neuroscience reports 20010301
What is the optimal strategy for managing acute migraine headaches? The Journal of family practice 20010201
A systematic review of the use of triptans in acute migraine. The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques 20010201
New abortive agents for the treatment of migraine. Advances in internal medicine 20010101
NMR studies on three optical active drug molecules. Acta poloniae pharmaceutica 20010101
The cost effectiveness of stratified care in the management of migraine. PharmacoEconomics 20010101
Triptans in the treatment of basilar migraine and migraine with prolonged aura. Headache 20010101
Sumatriptan: pharmacological basis and clinical results. Current medical research and opinion 20010101
Zolmitriptan: differences from sumatriptan. Current medical research and opinion 20010101
Comparative aspects of triptans in treating migraine. Clinical cornerstone 20010101

© 2019 Angene International Limited. All rights Reserved.